<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ARYX News</title><copyright>Copyright (c) 2010 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=aryx</link><description>Latest Financial News for ARYx Therapeutics, Inc.</description><language>en-us</language><lastBuildDate>Tue, 5 Jan 2010 18:05:23 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Aryx gets FDA guidance on blood clot drug that failed trial (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kvoee09/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2010/01/04/daily19.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/2518023574</guid><pubDate>Tue, 5 Jan 2010 18:05:23 Etc/GMT</pubDate></item><item><title>UPDATE - ARYx says FDA backs anticlotting agent development path (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh77710_2010-01-05_14-27-44_sge6040ft_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/4293913790</guid><pubDate>Tue, 5 Jan 2010 14:27:44 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/100105/aryx8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1576714463</guid><pubDate>Tue, 5 Jan 2010 13:31:03 Etc/GMT</pubDate></item><item><title>InPlay: Aryx Therapeutics receives guidance on anticoagulant agent tecarfarin (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/mp#aryx</link><description></description><guid isPermaLink="false">yahoo_finance/3140851579</guid><pubDate>Tue, 5 Jan 2010 13:01:54 Etc/GMT</pubDate></item><item><title>ARYx Therapeutics Receives Guidance on Anticoagulant Agent Tecarfarin (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100105/20100105005110.html?.v=1</link><description>FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, today announced that is has received guidance in writing from the U.S. Food and Drug Administration confirming that the existing development pathway remains acceptable to seek regulatory approval of ARYx’s novel anticoagulant agent, tecarfarin .</description><guid isPermaLink="false">yahoo_finance/1943278438</guid><pubDate>Tue, 5 Jan 2010 13:00:00 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=aryx</link><description></description><guid isPermaLink="false">yahoo_finance/1103522994</guid><pubDate>Wed, 18 Nov 2009 14:04:45 Etc/GMT</pubDate></item><item><title>Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091118/20091117006781.html?.v=1</link><description>FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx’s compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.</description><guid isPermaLink="false">yahoo_finance/3469724918</guid><pubDate>Wed, 18 Nov 2009 05:00:00 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for ARYx Therapeutics, Inc. (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/a/aryx.html</link><description></description><guid isPermaLink="false">yahoo_finance/3574009782</guid><pubDate>Sun, 15 Nov 2009 14:21:44 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091113/aryx10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/936853908</guid><pubDate>Fri, 13 Nov 2009 11:03:33 Etc/GMT</pubDate></item><item><title>Aryx Therapeutics reports $8.2M loss (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12khnouoa/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/11/09/daily95.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/2845621472</guid><pubDate>Thu, 12 Nov 2009 18:05:26 Etc/GMT</pubDate></item><item><title>Third Quarter 2009 Results and Earnings Call scheduled for 11:00 am ET today (Shareholder.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/9/109389.html</link><description></description><guid isPermaLink="false">yahoo_finance/4051551514</guid><pubDate>Thu, 12 Nov 2009 16:00:00 Etc/GMT</pubDate></item><item><title>ARYx Therapeutics Reports Third Quarter 2009 Results (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091112/20091112005292.html?.v=1</link><description>FREMONT, Calif.----ARYx Therapeutics, Inc. today reported results of operations and provided a general business update for the third quarter ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/2208657097</guid><pubDate>Thu, 12 Nov 2009 13:00:00 Etc/GMT</pubDate></item><item><title>Q3 2009 ARYx Therapeutics Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091112.html?t=aryx</link><description></description><guid isPermaLink="false">yahoo_finance/249415746</guid><pubDate>Thu, 12 Nov 2009 12:07:23 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/aryx8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/21524356</guid><pubDate>Thu, 12 Nov 2009 11:07:42 Etc/GMT</pubDate></item><item><title>ARYx Therapeutics Schedules Third Quarter 2009 Results Conference Call (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005061.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1671437981</guid><pubDate>Thu, 5 Nov 2009 13:00:00 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Other Events, Financia (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091102/aryx8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1301012925</guid><pubDate>Mon, 2 Nov 2009 21:39:31 Etc/GMT</pubDate></item><item><title>ARYx to Present at the Oppenheimer Annual Healthcare Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091030/20091030005023.html?.v=1</link><description>FREMONT, Calif.----ARYx Therapeutics, Inc. today announced that it will present at the Oppenheimer 20th Annual Healthcare Conference in New York on November 4, 2009 at 10:15 am Eastern.</description><guid isPermaLink="false">yahoo_finance/3656062217</guid><pubDate>Fri, 30 Oct 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Revlon, Micromet: Early Volume Plays (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12su71c51/*http%3A//www.thestreet.com/_yahoo/story/10618799/1/revlon-micromet-early-volume-plays.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/2870633895</guid><pubDate>Thu, 29 Oct 2009 13:32:14 Etc/GMT</pubDate></item><item><title>ARYx Therapeutics Aligns Operations to Development Activities (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091029/20091029005373.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/239380717</guid><pubDate>Thu, 29 Oct 2009 12:00:00 Etc/GMT</pubDate></item><item><title>ARYX THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091008/aryx8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2177596800</guid><pubDate>Thu, 8 Oct 2009 10:01:49 Etc/GMT</pubDate></item></channel></rss><!-- c17.finance.sp2.yahoo.com compressed/chunked Tue Jan  5 22:19:41 PST 2010 -->
